Your browser doesn't support javascript.
loading
ZBTB33 is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicing.
Beauchamp, Ellen M; Leventhal, Matthew; Bernard, Elsa; Hoppe, Emma R; Todisco, Gabriele; Creignou, Maria; Gallì, Anna; Castellano, Cecilia A; McConkey, Marie; Tarun, Akansha; Wong, Waihay; Schenone, Monica; Stanclift, Caroline; Tanenbaum, Benjamin; Malolepsza, Edyta; Nilsson, Björn; Bick, Alexander G; Weinstock, Joshua S; Miller, Mendy; Niroula, Abhishek; Dunford, Andrew; Taylor-Weiner, Amaro; Wood, Timothy; Barbera, Alex; Anand, Shankara; Psaty, Bruce M; Desai, Pinkal; Cho, Michael H; Johnson, Andrew D; Loos, Ruth; MacArthur, Daniel G; Lek, Monkol; Neuberg, Donna S; Lage, Kasper; Carr, Steven A; Hellstrom-Lindberg, Eva; Malcovati, Luca; Papaemmanuil, Elli; Stewart, Chip; Getz, Gad; Bradley, Robert K; Jaiswal, Siddhartha; Ebert, Benjamin L.
Afiliação
  • Beauchamp EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Leventhal M; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Bernard E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Hoppe ER; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Todisco G; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Creignou M; Computational Biology Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Gallì A; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Castellano CA; Department of Genome Sciences, University of Washington, Seattle, Washington.
  • McConkey M; Department of Molecular Medicine, University of Pavia, and Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Tarun A; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Wong W; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Schenone M; Department of Molecular Medicine, University of Pavia, and Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Stanclift C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Tanenbaum B; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Malolepsza E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Nilsson B; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Bick AG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Weinstock JS; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Miller M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Niroula A; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Dunford A; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Taylor-Weiner A; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Wood T; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Barbera A; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Anand S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Psaty BM; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Desai P; Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Cho MH; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Johnson AD; Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Loos R; Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • MacArthur DG; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Lek M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Neuberg DS; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Lage K; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Carr SA; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Hellstrom-Lindberg E; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Malcovati L; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Papaemmanuil E; Cardiovascular Health Research Unit, Departments of Medicine, Epidemiology, and Health Services, University of Washington, Seattle, Washington.
  • Stewart C; Kaiser Permanente Washington Health Research Institute, Seattle, Washington.
  • Getz G; Division of Hematology and Oncology, Weill Cornell Medical College, New York, New York.
  • Bradley RK; Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Jaiswal S; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Ebert BL; National Heart, Lung, and Blood Institute Center for Population Studies, the Framingham Heart Study, Framingham, Massachusetts.
Blood Cancer Discov ; 2(5): 500-517, 2021 09.
Article em En | MEDLINE | ID: mdl-34568833
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Hematopoiese Clonal Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Cancer Discov Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Hematopoiese Clonal Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Cancer Discov Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos